This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Illumina Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Gwenn Berry - Innovator in Genomic Technologies
Introduction
Gwenn Berry is an accomplished inventor based in San Diego, CA. She currently works at Illumina Corporation, a leading company in the field of genomic technologies. Although she does not hold any granted patents, her contributions to the field are significant through her innovative patent applications.
Latest Patent Applications
Gwenn Berry has been involved in several notable patent applications. One of her latest applications is titled "Oncogenic Splice Variant Determination." This application presents systems and methods for identifying splice variants. The techniques include determining one or more sample splice junctions from a plurality of RNA sequence reads from a single biological sample. It also involves retrieving a set of baseline splice junctions determined from a plurality of healthy RNA samples and comparing the sample splice junctions to the baseline splice junctions to identify candidate oncogenic events.
Another significant application is "Validation Methods and Systems for Sequence Variant Calls." This application provides methods and systems for validating variant calls. It includes receiving sequencing data for a sample read along the genomic sequence of interest and obtaining baseline variant frequencies at designated positions within one or more baseline genomic sequences. The methods analyze the baseline and sample variant frequencies to obtain a quality score and validate potential variant calls based on this score.
Conclusion
Gwenn Berry is a dedicated inventor whose work at Illumina Corporation focuses on advancing genomic technologies through innovative patent applications. Her contributions are paving the way for future developments in the field.